Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder
30 août 2018 14h53 HE
|
Sen-Jam Pharmaceutical
HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly complex and multifaceted problem facing America. We wanted to investigate the developments in medications,...
BioCorRx, Inc. Announces New Program and Outlines Growth Strategy in Special Letter to Shareholders
17 sept. 2015 08h00 HE
|
BioCorRx
Los Angeles, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Dear Fellow Shareholder,
I am writing today to reintroduce you to BioCorRx, Inc. (OTCQB: BICX) and bring you up to date on our recent progress and our...
BioCorRx to Present at 10th Annual Singular Research Investor Conference on September 17, 2015
10 sept. 2015 08h00 HE
|
BioCorRx
Los Angeles, Sept. 10, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQX: BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, today announced that Brady...